To test the relevance of DRD3 signalling on CD8+ T-cells in the anti-tumour response, a mouse model of melanoma was induced in mice bearing Drd3-sufficient or Drd3-deficient tumour-specific CD8+ T-cells. This evidence concerns the gene DRD3 and melanoma.